HYBRID EVENT: You can participate in person at Paris, France or Virtually from your home or work.

2nd Edition of International Conference on Tissue Engineering and Regenerative Medicine

September 16-17, 2022 | Paris, France

September 16 -17, 2022 | Paris, France
TERMC 2021

Characterization of Mesenchymal Stem Cells (MSCs) and their use in the treatment of COVID-19.

Vasiliki E Kalodimou, Speaker at Speaker for Tissue Engineering Conference - Vasiliki E. Kalodimou
Director Flow Cytometry-Research & Regenerative Medicine Department, Greece
Title : Characterization of Mesenchymal Stem Cells (MSCs) and their use in the treatment of COVID-19.

Abstract:

  • Discuss the history and properties of MSCs
  • Discuss rationale for use of uMSC in COVID-19
  • Present institutional Protocol for use of uMSC in COVID-19  pneumonia
  • Present local experience and outcome of patients treated with  uMSC with COVID-19

Biography:

Vasiliki E. Kalodimou is the Collaborative partner for training and research for Regenerative Medicine Program at the Institute of Personalized Molecular Medicine at the Medical City Hospital, Philippines, the Board/Committee on Research Ethics at the National Hellenic Research Foundation, the Vice-Chair of the UEL Alumni Advisory Board,  previously was the Director at the Flow Cytometry-Research and Regenerative Medicine Department of IASO in Greece, as well as the CBB & Processing Facility Director at MedStem-Cryobanks. In addition to collaboration with state universities and pharmaceutical companies on research projects (17), frequently publishes (46 & 9 books) her findings. She has 2 patents.

Watsapp